DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2231204/select-medical-sem-q4-earnings-beat-on-patient-admissions?cid=CS-ZC-FT-analyst_blog|earnings_article-2231204 Feb 23, 2024 - Select Medical's (SEM) Q4 results reflect strong segmental contribution, aided by higher patient days and visits. Management expects 2024 adjusted EBITDA to be $830-$880 million, up from the 2023 reported figure of $807.4 million. 0

https://www.zacks.com/stock/news/2224783/why-zimmer-biomet-zbh-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2224783 Feb 12, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. 0

https://www.zacks.com/stock/news/2223473/zimmer-biomet-zbh-q4-earnings-top-estimates-margins-grow?cid=CS-ZC-FT-analyst_blog|earnings_article-2223473 Feb 08, 2024 - Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER in the fourth quarter. 0

https://www.zacks.com/stock/news/2220902/curious-about-zimmer-zbh-q4-performance-explore-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220902 Feb 05, 2024 - Get a deeper insight into the potential performance of Zimmer (ZBH) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. 0

https://www.zacks.com/stock/news/2213563/what-s-in-store-for-zimmer-biomet-zbh-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213563 Jan 22, 2024 - Zimmer Biomet (ZBH) is expected to have gained from the uptake of Persona OsseoTi Keel Tibia for Cementless Knee Replacement in the fourth quarter. 0

https://www.zacks.com/stock/news/2204891/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2204891 Jan 03, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. 0